Detection of PCV2d in Vaccinated Pigs in Colombia and Prediction of Vaccine T Cell Epitope Coverage against Circulating Strains Using EpiCC Analysis.

Autor: Vargas-Bermudez DS; Universidad Nacional de Colombia, Sede Bogotá, Facultad de Medicina Veterinaria y de Zootecnia, Centro de Investigación en Infectología e Inmunología Veterinaria (CI3V), Bogotá 111321, Colombia., Gil-Silva AC; Zoetis de Colombia, Titan Plaza Centro Empresarial, Bogotá 111021, Colombia., Naranjo-Ortíz MF; Universidad Nacional de Colombia, Sede Bogotá, Facultad de Medicina Veterinaria y de Zootecnia, Centro de Investigación en Infectología e Inmunología Veterinaria (CI3V), Bogotá 111321, Colombia., Mogollón JD; Universidad Nacional de Colombia, Sede Bogotá, Facultad de Medicina Veterinaria y de Zootecnia, Centro de Investigación en Infectología e Inmunología Veterinaria (CI3V), Bogotá 111321, Colombia., Gómez-Betancur JF; Zoetis de Colombia, Titan Plaza Centro Empresarial, Bogotá 111021, Colombia., Estrada JF; Zoetis de Colombia, Titan Plaza Centro Empresarial, Bogotá 111021, Colombia., Aldaz Á; Zoetis Inc., 10 Sylvan Way, Parsippany, NJ 07054, USA., Garzón-González H; Grupo de Investigación en Ciencias Biomédicas (GICBUPTC), Universidad Pedagógica y Tecnológica de Colombia (UPTC), Tunja 150003, BOY, Colombia., Angulo J; Zoetis Inc., 1040 Swabia Ct, Durham, NC 27703, USA., Foss D; Zoetis Inc., 333 Portage St, Kalamazoo, MI 49007, USA., Gutierrez AH; EpiVax Inc., Providence, RI 02909, USA., Jaime J; Universidad Nacional de Colombia, Sede Bogotá, Facultad de Medicina Veterinaria y de Zootecnia, Centro de Investigación en Infectología e Inmunología Veterinaria (CI3V), Bogotá 111321, Colombia.

Publikováno v: Vaccines [Vaccines (Basel)] 2024 Sep 29; Vol. 12 (10). Date of Electronic Publication: 2024 Sep 29.

Fecal microbiota transplantation from female donors restores gut permeability and reduces liver injury and inflammation in middle-aged male mice exposed to alcohol.

Autor: Lamas-Paz A; Department of Immunology, Ophthalmology and Eye Nose and Throat (ENT), Complutense University School of Medicine, Madrid, Spain.; 12 de Octubre Health Research Institute (imas12), Madrid, Spain., Mesquita M; Department of Immunology, Ophthalmology and Eye Nose and Throat (ENT), Complutense University School of Medicine, Madrid, Spain.; State University of Campinas, Campinas, SP, Brazil., Garcia-Lacarte M; Department of Biochemistry and Genetics, Universidad de Navarra, Pamplona, Spain.; Cancer Center Clínica Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain., Estévez-Vázquez O; Department of Immunology, Ophthalmology and Eye Nose and Throat (ENT), Complutense University School of Medicine, Madrid, Spain., Benedé-Ubieto R; Department of Immunology, Ophthalmology and Eye Nose and Throat (ENT), Complutense University School of Medicine, Madrid, Spain., Gutierrez AH; Department of Immunology, Ophthalmology and Eye Nose and Throat (ENT), Complutense University School of Medicine, Madrid, Spain., Wu H; Department of Immunology, Ophthalmology and Eye Nose and Throat (ENT), Complutense University School of Medicine, Madrid, Spain., Leal Lasalle H; Department of Immunology, Ophthalmology and Eye Nose and Throat (ENT), Complutense University School of Medicine, Madrid, Spain., Vaquero J; Servicio de Aparato Digestivo, Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Madrid, Spain., Bañares R; Servicio de Aparato Digestivo, Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Madrid, Spain., Martínez-Naves E; Department of Immunology, Ophthalmology and Eye Nose and Throat (ENT), Complutense University School of Medicine, Madrid, Spain.; 12 de Octubre Health Research Institute (imas12), Madrid, Spain., Roa S; Department of Biochemistry and Genetics, Universidad de Navarra, Pamplona, Spain.; Cancer Center Clínica Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain., Nevzorova YA; Department of Immunology, Ophthalmology and Eye Nose and Throat (ENT), Complutense University School of Medicine, Madrid, Spain.; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Madrid, Spain., Jorquera G; Centro de Neurobiología y Fisiopatología Integrativa (CENFI), Facultad de Ciencias, Universidad de Valparaíso, Valparaíso, Chile.; Instituto de Nutrición y Tecnología de los Alimentos, Universidad de Chile, Santiago, Chile., Cubero FJ; Department of Immunology, Ophthalmology and Eye Nose and Throat (ENT), Complutense University School of Medicine, Madrid, Spain.; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Madrid, Spain.

Publikováno v: Frontiers in nutrition [Front Nutr] 2024 Apr 18; Vol. 11, pp. 1393014. Date of Electronic Publication: 2024 Apr 18 (Print Publication: 2024).

A SARS-CoV-2 NSP7 homolog of a Treg epitope suppresses CD4+ and CD8+ T cell memory responses.

Autor: Miah SMS; EpiVax, Inc., Providence, RI, United States., Lelias S; EpiVax, Inc., Providence, RI, United States., Gutierrez AH; EpiVax, Inc., Providence, RI, United States., McAllister M; EpiVax, Inc., Providence, RI, United States., Boyle CM; EpiVax, Inc., Providence, RI, United States., Moise L; EpiVax, Inc., Providence, RI, United States., De Groot AS; EpiVax, Inc., Providence, RI, United States.; Center for Vaccines and Immunology, University of Georgia, Athens, GA, United States.

Publikováno v: Frontiers in immunology [Front Immunol] 2023 Nov 24; Vol. 14, pp. 1290688. Date of Electronic Publication: 2023 Nov 24 (Print Publication: 2023).

Is Evolutionary Conservation a Useful Predictor for Cancer Long Noncoding RNAs? Insights from the Cancer LncRNA Census 3.

Autor: Vancura A; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, 3010 Bern, Switzerland.; Graduate School of Cellular and Biomedical Sciences, University of Bern, 3012 Bern, Switzerland.; Department for BioMedical Research, University of Bern, 3008 Bern, Switzerland.; HMS Initiative for RNA Medicine, Department of Pathology, Beth Israel Deaconess Medical Center Cancer Center, Harvard Medical School, Boston, MA 02215, USA., Gutierrez AH; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, 3010 Bern, Switzerland.; Department for BioMedical Research, University of Bern, 3008 Bern, Switzerland., Hennig T; HMS Initiative for RNA Medicine, Department of Pathology, Beth Israel Deaconess Medical Center Cancer Center, Harvard Medical School, Boston, MA 02215, USA., Pulido-Quetglas C; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, 3010 Bern, Switzerland.; Graduate School of Cellular and Biomedical Sciences, University of Bern, 3012 Bern, Switzerland.; Department for BioMedical Research, University of Bern, 3008 Bern, Switzerland., Slack FJ; HMS Initiative for RNA Medicine, Department of Pathology, Beth Israel Deaconess Medical Center Cancer Center, Harvard Medical School, Boston, MA 02215, USA., Johnson R; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, 3010 Bern, Switzerland.; Department for BioMedical Research, University of Bern, 3008 Bern, Switzerland.; School of Biology and Environmental Science, University College Dublin, D04 V1W8 Dublin, Ireland.; Conway Institute of Biomedical and Biomolecular Research, University College Dublin, D04 V1W8 Dublin, Ireland., Haefliger S; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, 3010 Bern, Switzerland.; Department for BioMedical Research, University of Bern, 3008 Bern, Switzerland.

Publikováno v: Non-coding RNA [Noncoding RNA] 2022 Dec 07; Vol. 8 (6). Date of Electronic Publication: 2022 Dec 07.

Cancer LncRNA Census 2 (CLC2): an enhanced resource reveals clinical features of cancer lncRNAs.

Autor: Vancura A; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern 3010, Switzerland., Lanzós A; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern 3010, Switzerland., Bosch-Guiteras N; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern 3010, Switzerland., Esteban MT; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern 3010, Switzerland., Gutierrez AH; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern 3010, Switzerland., Haefliger S; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern 3010, Switzerland., Johnson R; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern 3010, Switzerland.

Publikováno v: NAR cancer [NAR Cancer] 2021 Apr 14; Vol. 3 (2), pp. zcab013. Date of Electronic Publication: 2021 Apr 14 (Print Publication: 2021).